Welcome to LookChem.com Sign In|Join Free
  • or
2-azidoethyl 4,6-O-benzylidene-2-deoxy-2-N-phthalimido-β-D-glucopyranoside is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

169151-52-4

Post Buying Request

169151-52-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

169151-52-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 169151-52-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,9,1,5 and 1 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 169151-52:
(8*1)+(7*6)+(6*9)+(5*1)+(4*5)+(3*1)+(2*5)+(1*2)=144
144 % 10 = 4
So 169151-52-4 is a valid CAS Registry Number.

169151-52-4Downstream Products

169151-52-4Relevant academic research and scientific papers

A peptide-free, liposome-based oligosaccharide vaccine, adjuvanted with a natural killer T cell antigen, generates robust antibody responses in vivo

Deng,Bai,Reboulet,Matthew,Engler,Teyton,Bendelac,Savage

, p. 1437 - 1441 (2014/03/21)

Due to the prevalence of oligo- and polysaccharides on the surfaces of pathogenic organisms, carbohydrates are primary targets for recognition by antibodies generated by the immune systems of higher organisms. Consequently, substantial effort has been expended in efforts to develop vaccines based on carbohydrate epitopes. Typical approaches involve multivalent presentation of carbohydrate targets on antigenic peptides or proteins, which often involve substantial synthetic commitments and/or vaccines that are heterogeneous and difficult to characterize. We have developed a simple, liposome-based approach to generate multivalent carbohydrate vaccines, and in place of an antigenic peptide or protein, we have used a potent antigen for natural killer T cells. This vaccine, based on the Streptococcus pneumoniae serotype 14 polysaccharide, gave a response superior to that from a clinically used vaccine (Prevnar). The dependence of this response on liposome formation was demonstrated by comparison to a simple mixture of the oligosaccharide and the natural killer T cell adjuvant. The importance of the strength of the adjuvant was observed by use of a potent synthetic adjuvant and a weaker, bacterial derived glycolipid adjuvant. These results demonstrate the effectiveness of this novel and relatively simple means of generating carbohydrate-based vaccines.

Synthesis of a monophosphoryl lipid A derivative and its conjugation to a modified form of a tumor-associated carbohydrate antigen GM3

Wang, Qianli,Xue, Jie,Guo, Zhongwu

supporting information; experimental part, p. 5536 - 5537 (2010/01/31)

An efficient synthesis of a derivative of monophosphoryl lipid A suitable for coupling to various structures for the construction of glycoconjugate vaccines and its conjugation with an N-modified form of the tumor-associated antigen GM3 is presented.

Pentaerythritol as the core of multivalent glycolipids: Synthesis of a glycolipid with three SO3Lea ligands

Xue, Jie,Zhu, Junmin,Marchant, Roger E.,Guo, Zhongwu

, p. 3753 - 3756 (2007/10/03)

(Chemical Equation Presented) A glycolipid containing three SO 3Lea ligands was synthesized with pentaerythritol as the core. The glycolipid was used to prepare glycoliposomes that showed stability similar to that of DSPC liposomes w

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 169151-52-4